<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recent studies have demonstrated that Kisspeptin, the product of the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> suppressor gene KiSS-1, could have a role in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and invasion </plain></SENT>
<SENT sid="1" pm="."><plain>In this pilot study, we investigated the association of plasma Kisspeptin-54 level with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Plasma Kisspeptin-54 levels were quantified using enzyme-immunoassay (EIA) kits from blood samples of 81 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> at their initial staging and 59 age-matched healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Plasma Kisspeptin-54 levels were significantly higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients (86.2 ± 20.5) than in controls (49 ± 12.7; p &lt; 0.005) </plain></SENT>
<SENT sid="4" pm="."><plain>The cutoff value for Kisspeptin-54 detection was determined as 46 ng/ml, and area under curve (AUC) value was 0.766 with sensitivity 63 %, specificity 81.4 %, positive predictive value 82.2 %, negative predictive value 61.5 %, positive likelihood ratio 3.38, and negative likelihood ratio 0.46 </plain></SENT>
<SENT sid="5" pm="."><plain>Increased plasma Kisspeptin-54 levels were significantly correlated with nodal involvement of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (Spearman, rs = 0.345, p = 0.002) </plain></SENT>
<SENT sid="6" pm="."><plain>Kisspeptin-54 was also found to be an independent predictive marker for <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (p = 0; Exp(B): 2.053; 95 % CI, 1.255-2.851) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Our results reveal that plasma Kisspeptin-54 measurement could be a useful diagnostic and prognostic parameter for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Further prospective evaluation is needed to validate these findings and to establish the clinical usefulness of Kisspeptin-54 for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> diagnostics </plain></SENT>
</text></document>